|
|
|
|
L : Workshop 1: Mucositis research workshop
|
|
07:35
|
2016 MUCOSITIS NEWS - LITERATURE HIGHLIGHTS
Paolo Bossi, Italy
|
|
|
|
|
|
|
|
07:50
|
ANIMAL MODELS FOR ORAL MUCOSITIS – FROM HAMSTER CHEEK POUCH TO MTOR-INH. ASSOCIATED STOMATITIS MODEL
Stephen T. Sonis, USA
|
|
|
|
|
|
|
|
08:20
|
NALOXONE ADMINISTRATION IS ASSOCIATED WITH INCREASED TUMOUR GROWTH FOLLOWING IRINOTECAN IN A RAT BREAST CANCER MODEL
J. Bowen, Australia
|
|
|
|
|
|
|
|
08:40
|
NEURON AND GLIAL CHANGE IS ASSOCIATED WITH IRINOTECAN-INDUCED MUCOSITIS IN A TUMOUR BEARING DA RAT MODEL
Daniel Thorpe, Australia
|
|
|
|
|
|
|
|
08:50
|
TNF-? INHIBITOR ETANERCEPT DOES NOT ALTER THE SEVERITY OF METHOTREXATE-INDUCED GASTROINTESTINAL MUCOSITIS IN THE RAT
N. Kuiken, Netherlands
|
|
|
|
|
|
|
|
09:00
|
OPEN DISCUSSION
Wim Tissing, Netherlands
|
|
|
|
|
|
|
|
09:35
|
IS CRYOTHERAPY BENEFICIAL IN REDUCING THE INCIDENCE OF ORAL MUCOSITIS DURING AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH NON-HODGKIN LYMPHOMA RECEIVING HIGH DOSE MELPHALAN?
J. Toro, USA
|
|
|
|
|
|
|
|
09:45
|
POTENTIAL OF ST-617 TO PREVENT THE OCCURRENCE AND REDUCE THE DURATION OF SEVERE ORAL MUCOSITIS
B. Framroze, India
|
|
|
|
|
|
|
|
09:55
|
HANGESHASHINTO PREVENTS ORAL MUCOSITIS UNDER CHEMORADIOTHERAPY TO HEAD AND NECK CANCER
T. Tamahara, Japan
|
|
|
|
|
|
|
|
10:05
|
SINGLE NUCLEOTIDE POLYMORPHISM (SNP) OF TAC 1 GENE IN PATIENTS EXPOSED TO RADIATION THERAPY FOR HEAD AND NECK CANCERS
S. PS, Kingdom of Saudi Arabia
|
|
|
|
|
|
|
|
10:20
|
PHOTOBIOMODULATION – CURRENT SCIENCE AND ITS APPLICATION FOR ORAL MUCOSITIS
Praveen Arany, USA
|
|
|
|
|
|
|
|
10:55
|
EXPERT PANEL, OPEN DISCUSSION: (RACHEL GIBSON, AUSTRALIA) (STEVE SONIS, USA), (JOANNE BOWEN, AUSTRALIA), (PRAVEEN ARANY, USA), (PAOLO BOSSI, ITALY)
Panel
|
|
|
|
|
|
L : Opening Ceremony
|
|
13:05
|
WELCOME FROM PRESIDENT
Ian Olver, Australia
|
|
|
|
|
|
|
|
13:10
|
OPENING BY THE GOVERNOR OF SOUTH AUSTRALIA: HIS EXCELLENCY THE HONOURABLE HIEU VAN LE AO
Hieu Van
|
|
|
|
|
|
|
|
13:20
|
WORDS FROM MEETING CO-CHAIR:
Dorothy M. K. Keefe, Australia
|
|
|
|
|
|
|
|
13:24
|
ISOO WELCOME:
Ourania Nicolatou-Galitis, Greece
|
|
|
|
|
|
|
|
13:28
|
PRESIDENTIAL ADDRESS AND DISTINGUISHED SERVICE AWARD PRESENTATION:
Ian Olver, Australia
|
|
|
|
|
|
L : Plenary 1: 25 Years of MASCC and future
|
|
13:47
|
FOUNDING MASCC AND THE EARLY YEARS
Jean Klastersky, Belgium
|
|
|
|
|
|
|
|
14:09
|
AN OVERVIEW OF MASCC’S STORY AND SUCCESSES BY THE PAST PRESIDENTS OF MASCC
Matti Aapro, Switzerland
|
|
|
|
|
|
|
|
14:20
|
AN OVERVIEW OF MASCC’S STORY AND SUCCESSES BY THE PAST PRESIDENTS OF MASCC
Paul Hesketh, USA
|
|
|
|
|
|
|
|
14:31
|
AN OVERVIEW OF MASCC’S STORY AND SUCCESSES BY THE PAST PRESIDENTS OF MASCC
Jørn Herrstedt, Denmark
|
|
|
|
|
|
|
|
14:42
|
AN OVERVIEW OF MASCC’S STORY AND SUCCESSES BY THE PAST PRESIDENTS OF MASCC
Dorothy M. K. Keefe, Australia
|
|
|
|
|
|
|
|
14:53
|
AN OVERVIEW OF MASCC’S STORY AND SUCCESSES BY THE PAST PRESIDENTS OF MASCC
Dave Warr, Canada
|
|
|
|
|
|
|
|
15:04
|
THE NEXT 25 YEARS OF SUPPORTIVE CARE AND MASCC
Stephen T. Sonis, USA
|
|
|
|
|
|
L : Parallel 01: Disparities in supportive care in cancer
|
|
15:47
|
DISPARITIES. DISPARITIES IN SUPPORTIVE CARE IN PAPUA NEW GUINEA
Dadi Toka, Papua New Guinea
|
|
|
|
|
|
|
|
16:31
|
DISPARITIES IN SUPPORTIVE CARE IN INDIA
Raju Chacko, India
|
|
|
|
|
|
L : Parallel 05: Supportive care from the patient expert perspective
|
|
17:32
|
VIEW FROM THE BOTH SIDES OF THE ROOM
Mark Schubert, USA
|
|
|
|
|
|
|
|
17:54
|
R-CHOP NOT SO EASY ON THE RECEIVING SIDE
Ian Hewson, Australia
|
|
|
|
|
|
|
|
18:16
|
MANAGING LIVING WITH CANCER
Pam Nielsen, Australia
|
|
|
|
|
|
|
|
18:38
|
FEASIBILITY, ACCEPTABILITY AND IMPACT OF A PRO-ACTIVE TELEPHONE-BASED INTERVENTION TO IMPROVE TOXICITY MANAGEMENT DURING CHEMOTHERAPY FOR EARLY STAGE BREAST CANCER
Monika Krzyzanowska, Canada
|
|
|
|
|
|
|
|
18:48
|
PATIENT REPORTED OUTCOME MEASUREMENT: SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER CARE - ONTARIO HEALTHCARE PROFESSIONALS' ATTITUDES, THE EDMONTON SYMPTOM ASSESSMENT SYSTEM (ESAS) AND THE ROAD AHEAD
Monika Krzyzanowska, Canada
|
|
|
|
|
|
L2 : Workshop 4: End of life: Global care, local solutions
|
|
08:05
|
WHAT IS A GOOD DEATH?
Andrew Davies, United Kingdom
|
|
|
|
|
|
|
|
08:25
|
PROGNOSTICATION IN ADVANCED CANCER PATIENTS
David Hui, USA
|
|
|
|
|
|
|
|
08:45
|
ADVANCE CARE PLANNING
Teresa Burgess, Australia
|
|
|
|
|
|
|
|
09:05
|
MANAGEMENT OF SYMPTOMS AT END-OF-LIFE
Mellar Davis, USA
|
|
|
|
|
|
|
|
09:55
|
MODELS OF EOLC IN HOSPITAL
Dorothy M. K. Keefe, Australia
|
|
|
|
|
|
|
|
10:35
|
PROVISION OF END OF LIFE CARE FOR ABORIGINAL PEOPLES
Sally Banfield, Australia
|
|
|
|
|
|
|
|
10:55
|
PSYCHOLOGICAL IMPACT ON HEALTHCARE PROFESSIONALS OF CARING FOR DYING PATIENTS
Gregory Crawford, Australia
|
|
|
|
|
|
L2 : Educational Session: How to write a manuscript for supportive care in cancer
|
|
11:35
|
THE EDITORS VIEW
Fredrick Ashbury, Canada
|
|
|
|
|
|
|
|
11:55
|
THE AUTHOR'S VIEW
Ian Olver, Australia
|
|
|
|
|
|
|
|
12:15
|
THE REVIEWER'S VIEW
Jørn Herrstedt, Denmark
|
|
|
|
|
|
|
|
12:55
|
CONCLUSION
Fredrick Ashbury, Canada
|
|
|
|
|
|
L2 : Parallel 04: Young investigator Award Session
|
|
15:47
|
HIGH SENSITIVE CARDIAC TROPONIN T ASSAY CAN RELIABLY PREDICT EARLY ANTHRACYCLINE AND TRASTUZUMAB CARDIOTOXICITY IN BREAST CANCER PATIENTS
Hiromitsu Kitayama, Japan
|
|
|
|
|
|
|
|
15:57
|
TOLL-LIKE RECEPTOR 4 (TLR4)-MEDIATED TIGHT JUNCTION DISRUPTION AND DYSREGULATED ION SECRETION ARE KEY DRIVERS OF IRINOTECAN-INDUCED DIARRHOEA
Hannah Wardill, Australia
|
|
|
|
|
|
|
|
16:07
|
FRACTIONATED RADIATION INDUCES DIFFERENTIAL EXPRESSION OF MATRIX METALLOPROTEINASES IN THE COLON
Romany Stansborough, Australia
|
|
|
|
|
|
|
|
16:17
|
DIFFERENTIATION OF GASTROINTESTINAL TOXICITY ASSOCIATED WITH DIFFERENT NANOPARTICLE FORMULATIONS IN A MALE SPRAGUE DAWLEY RAT 5-FLUROURACIL-INDUCED MUCOSITIS MODEL
Daniel Thorpe, Australia
|
|
|
|
|
|
|
|
16:27
|
A PROSPECTIVE STUDY VALIDATING THE EORTC QLQ–BM22 BONE METASTASES MODULE IN PATIENTS WITH PAINFUL BONE METASTASES
Srinivas Raman, Canada
|
|
|
|
|
|
|
|
16:37
|
EFFICACY OF OMEGA-3 (O-3) SUPPLEMENTATION VERSUS OMEGA-6 (O-6) SUPPLEMENTATION FOR REDUCING CANCER-RELATED FATIGUE AMONG BREAST CANCER SURVIVORS: A URCC NCORP RANDOMIZED CONTROLLED TRIAL
Luke Peppone, USA
|
|
|
|
|
|
|
|
16:47
|
MICROBIAL BIOMARKERS OF ORAL MUCOSITIS ONSET
Rebeca Vasconcelos, USA
|
|
|
|
|
|
|
|
16:57
|
IMPROVING DELIVERY AND DOCUMENTATION OF SUPPORTIVE CARE MANAGEMENT OF CANCER PATIENT IN RESOURCE-CONSTRAINED DEVELOPING COUNTRIES
Vinay Kumar Ramaiah, India
|
|
|
|
|
|
L2 : Parallel 08: Systematic review: update and outcomes measures (Oral Care Study Group)
|
|
17:40
|
GUIDELINE UPDATE ON THE ORAL COMPLICATIONS IN CANCER THERAPY
Deborah P. Saunders, Canada
|
|
|
|
|
|
|
|
18:05
|
GUIDELINE UPDATE ON THE ORAL COMPLICATIONS IN CANCER THERAPY A BIT ABOUT SPIT: WHAT WE KNOW ABOUT RADIATION AND XEROSTOMIA, IMRT AND PAROTID SPARING
John Wu, Canada
|
|
|
|
|
|
|
|
18:30
|
DENTAL DISEASE AND DENTAL TREATMENT PRIOR TO HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCST): ORASTEM STUDY
Allan Hovan, Canada
|
|
|
|
|
|
L3 : Parallel 29:Making Meaning, making special: a multi-media exploration of the role of the arts in cancer care
|
|
15:55
|
MAKING MEANING, MAKING SPECIAL: A MULTI-MEDIA EXPLORATION OF THE ROLE OF THE ARTS IN CANCER CARE
Sally Francis, Australia
|
|
|
|
|
|
|
|
15:45
|
MAKING MEANING, MAKING SPECIAL: A MULTI-MEDIA EXPLORATION OF THE ROLE OF THE ARTS IN CANCER CARE
Christine Putland, Australia
|
|
|
|
|
|
|
|
16:05
|
MAKING MEANING, MAKING SPECIAL: A MULTI-MEDIA EXPLORATION OF THE ROLE OF THE ARTS IN CANCER CARE
John Blines, Australia
|
|
|
|
|
|
L3 : Parallel 30: Managing stomatitis associated with everolimus in patients with hormone-receptor positive metastatic breast cancer
|
|
18:25
|
THE KEY TO SUCCESS: A NURSE’S PERSPECTIVE ON THE MANAGEMENT OF MIAS:
Jenny Gilchrist, Australia
|
|
|
|
|
|
M : Workshop 6: Nutritional care throughout the advanced cancer journey
|
|
09:15
|
MANAGEMENT OF NUTRITIONAL AND HYDRATION ISSUES IN THE LAST DAYS/WEEKS OF LIFE
David Hui, USA
|
|
|
|
|
|
|
|
09:55
|
KEY PUBLICATIONS ON NUTRITIONAL ISSUES: A YEAR IN REVIEW
Mellar Davis, USA
|
|
|
|
|
|
|
|
10:55
|
SUMMARY AND NEXT STEPS
Liz Isenring, Australia
|
|
|
|
|
|
M : Parallel 02: Is e-communication critical to the delivery of cancer care?
|
|
16:04
|
WHAT MIGHT E-COMMUNICATION BEST PRACTICE INVOLVE
Phyllis Butow, Australia
|
|
|
|
|
|
|
|
16:21
|
TELEMEDICINE IN RURAL AND REMOTE AUSTRALIA - OUTREACH AND DISPARITY
Ian Olver, Australia
|
|
|
|
|
|
|
|
17:05
|
TEXT MESSAGES TO EDUCATE, ENGAGE, AND MOTIVATE (TEEM TRIAL): PATIENT PERCEPTIONS OF TEXT MESSAGING TO SUPPLEMENT PATIENT COUNSELING AND IMPROVE MEDICATION ADHERENCE
Soha Ahrari, Canada
|
|
|
|
|
|
M : Parallel 06: Maintaining bone health in cancer (Bone Study Group)
|
|
17:32
|
CANCER BONE MICROENVIRONMENT: HOW TO MAINTAIN AND HOW TO IMPROVE AN ONGOING CHALLENGE
Winston Tan, USA
|
|
|
|
|
|
|
|
17:49
|
OSTEONECROSIS POST CANCER THERAPY
Alastair Goss, Australia
|
|
|
|
|
|
|
|
18:06
|
NEW TREATMENTS FOR CHEMOTHERAPY-INDUCED BONE LOSS
Cory Xian, Australia
|
|
|
|
|
|
|
|
18:40
|
PERSONALIZATION SUPPORTIVE CARE (CORRECTION OF ANEMIA, NEUTROPENIA, AND THE APPOINTMENT OF BONE-MODIFYING AGENTS)
Anton Snegovoy, Russia
|
|
|
|
|
|
|
|
18:50
|
MEDICATION-RELATED OSTEONECROSIS OF THE JAW IN ADVANCED CANCER PATIENTS: A MULTICENTER CASE REGISTRY STUDY
Deborah P. Saunders, Canada
|
|
|
|
|
|
N : Workshop 3: Supportive care and Immunotherapy
|
|
08:05
|
IMMUNE CHECKPOINT INHIBITORS AND ANTI PD1 ANTIBODIES IN CANCER THERAPY: MALIGNANT MELANOMA, NSCLC AND BEYOND
Bernardo L. Rapoport, South Africa
|
|
|
|
|
|
|
|
08:30
|
ORAL COMPLICATIONS OF IMMUNOTHERAPY
Joel Epstein, USA
|
|
|
|
|
|
|
|
08:55
|
SKIN COMPLICATIONS ASSOCIATED WITH IMMUNOTHERAPY
Vincent Sibaud, France
|
|
|
|
|
|
|
|
09:20
|
IMMUNE RELATED INFECTIONS, NEUROLOGICAL, ENDOCRINE AND PULMONARY ADVERSE EVENTS
Jean Klastersky, Belgium
|
|
|
|
|
|
|
|
09:45
|
OTHERS: UVITIS, COLITIS, HEPATIC AND OTHER GI IMMUNE RELATED ADVERSE EVENTS ASSOCIATED WITH ANTI CTL4 AND ANTI PD1 ANTIBODIES
Ronwyn van Eeden, South Africa
|
|
|
|
|
|
|
|
10:10
|
IMMUNE THERAPY IN THE ELDERLY
Matti Aapro, Switzerland
|
|
|
|
|
|
N : Parallel 03: Care of cancer survivors – putting evidence into practice
|
|
15:47
|
THE SOUTH AUSTRALIAN SURVIVORSHIP FRAMEWORK
Tracey Doherty , Australia
|
|
|
|
|
|
|
|
15:57
|
DEVELOPING A SURVIVORSHIP MONITORING TOOL FOR SOUTH AUSTRALIA
Marion Eckert, Australia
|
|
|
|
|
|
|
|
16:17
|
THE HEALTHY LIVING AFTER CANCER PARTNERSHIP PROJECT
Amanda Robertson, Australia
|
|
|
|
|
|
|
|
16:27
|
PATIENT REPORTED RANKING OF LATE SYMPTOMS AFTER BREAST AND PROSTATE CANCER AND THEIR INFLUENCE ON SELF INITIATED NUTRITIONAL THERAPIES – THE BEDFORD REAL WORLD STUDY
Robert Thomas, United Kingdom
|
|
|
|
|
|
|
|
16:37
|
THE IMPACT OF CHEMOTHERAPY ON COGNITIVE FUNCTION: A PROSPECTIVE, LONGITUDINAL COHORT STUDY IN TESTICULAR CANCER
Hayley Whitford, Australia
|
|
|
|
|
|
N : Parallel 07: Oral Proffered Papers
|
|
17:30
|
HOW DO I DO THAT AGAIN? VODCASTS FOR PATIENTS WITH FEEDING TUBES AND SWALLOWING DIFFICULTIES
Jenelle Loeliger, Australia
|
|
|
|
|
|
|
|
18:00
|
COMPARING PERSPECTIVES OF MEN WITH PROSTATE CANCER AND HEALTH CARE PROFESSIONALS ABOUT ACTIVE SURVEILLANCE
Margaret Fitch, Canada
|
|
|
|
|
|
|
|
18:10
|
THE IMPACT OF AN EDUCATIONAL PROGRAM ON PATIENT PRACTICES ON SAFE USE, STORAGE, AND DISPOSAL OF OPIOIDS IN A COMPREHENSIVE CANCER CENTER
Maxine de la cruz, USA
|
|
|
|
|
|
|
|
18:20
|
RESULTS OF EDUCATIONAL PROGRAM OF SUPPORTIVE CARE IN ONCOLOGY IN RUSSIA
Anton Snegovoy, Russia
|
|
|
|
|
|
|
|
18:30
|
DEVELOPING NATIONAL INDICATORS TO MEASURE PROGRESS IN PERSON-CENTRED CANCER CARE
Margaret Fitch, Canada
|
|
|
|